EP Patent

EP3389631A1 — Halobetasol foam composition and method of use thereof

Assigned to Therapeutics Inc · Expires 2018-10-24 · 8y expired

What this patent protects

The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol.

USPTO Abstract

The present invention provides a composition and method for treating various skin diseases. The composition is formulated as a foamable composition and includes the corticosteroid halobetasol.

Drugs covered by this patent

halobetasol-propionate (HALOBETASOL PROPIONATE)

Patent Metadata

Patent number: EP3389631A1
Jurisdiction: EP
Classification: —
Expires: 2018-10-24
Drug substance claim: No
Drug product claim: No
Assignee: Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.